⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 17, 2024

Figure S1 from N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma

Sofia Geroyska Isabel Mejia Alfred A. Chan Marian S. Navarrete Vijaya Pandey Samuel Kharpatin Juliana Noguti Feng Wang Daniel Srole Tsui‐Fen Chou James A. Wohlschlegel Elizabeta Nemeth Robert Damoiseaux David B. Shackelford Delphine J. Lee Begoña Díaz

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

NMT1 is a therapeutic target in lung carcinoma

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Geroyska et al. (2024) studied this question.

synapsesocial.com/papers/68e5833db6db643587520e55 https://doi.org/10.1158/2767-9764.27045907

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S10 from N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma2024
2Figure S2 from N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma2024
3Figure S6 from N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma2024
4Figure S11 from N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma2024
5Figure S8 from N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma2024